Literature DB >> 12799026

An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis.

Hedley C A Emsley1, Craig J Smith, Carole M Gavin, Rachel F Georgiou, Andy Vail, Elisa M Barberan, John M Hallenbeck, Gregory J del Zoppo, Nancy J Rothwell, Pippa J Tyrrell, Stephen J Hopkins.   

Abstract

Central nervous system and peripheral inflammation is important in the responses to ischaemic stroke, and may also predispose to its development. We aimed to identify (1) the extent to which a peripheral inflammatory response is activated in patients following acute stroke, and (2) whether there was evidence for preexisting peripheral inflammation. Thirty-six patients with ischaemic stroke within 12 h of onset of symptoms had serial blood samples taken up to 12 months for analysis of markers of inflammation. Thirty-six control subjects, individually matched for age, sex and degree of atherosclerosis, were also studied. Median C-reactive protein (CRP) was elevated, relative to controls (2.08 mg/l), from admission (4.31 mg/l) (p</=0.001) until 3 months (2.90 mg/l) (p</=0.01), the greatest elevation occurring at 5-7 days (17.67 mg/l) (p</=0.001). Elevations were also seen in erythrocyte sedimentation rate (ESR) and white blood cell (WBC) count until 3 months. Median plasma IL-6 was also elevated, relative to controls (9 pg/ml), by 24 h after onset of symptoms (22 pg/ml) (p</=0.01), and remained elevated at 5-7 days (23 pg/ml) (p</=0.01), but not at 3 months. Less marked elevations in these markers were seen in patients without evidence of infection except for IL-6, which was not increased in the absence of infection. These data provide evidence of an early and sustained peripheral inflammatory response to acute ischaemic stroke in patients with or without evidence of infection. The very early increase in concentrations of inflammatory markers after stroke may either be induced by stroke itself, or may indicate a preexisting inflammatory condition in stroke patients which may contribute to the development of stroke.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12799026     DOI: 10.1016/s0165-5728(03)00134-6

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  92 in total

1.  Ischemic stroke activates hematopoietic bone marrow stem cells.

Authors:  Gabriel Courties; Fanny Herisson; Hendrik B Sager; Timo Heidt; Yuxiang Ye; Ying Wei; Yuan Sun; Nicolas Severe; Partha Dutta; Jennifer Scharff; David T Scadden; Ralph Weissleder; Filip K Swirski; Michael A Moskowitz; Matthias Nahrendorf
Journal:  Circ Res       Date:  2014-10-31       Impact factor: 17.367

2.  Inflammatory and metalloproteinases profiles predict three-month poor outcomes in ischemic stroke treated with thrombolysis.

Authors:  Anna Maria Gori; Betti Giusti; Benedetta Piccardi; Patrizia Nencini; Vanessa Palumbo; Mascia Nesi; Antonia Nucera; Giovanni Pracucci; Paolina Tonelli; Eleonora Innocenti; Alice Sereni; Elena Sticchi; Danilo Toni; Paolo Bovi; Mario Guidotti; Maria Rosaria Tola; Domenico Consoli; Giuseppe Micieli; Rossana Tassi; Giovanni Orlandi; Maria Sessa; Francesco Perini; Maria Luisa Delodovici; Maria Luisa Zedde; Francesca Massaro; Rosanna Abbate; Domenico Inzitari
Journal:  J Cereb Blood Flow Metab       Date:  2017-03-07       Impact factor: 6.200

3.  Inflammation after stroke: mechanisms and therapeutic approaches.

Authors:  Muzamil Ahmad; Steven H Graham
Journal:  Transl Stroke Res       Date:  2010-06       Impact factor: 6.829

Review 4.  Exosome-mediated amplification of endogenous brain repair mechanisms and brain and systemic organ interaction in modulating neurological outcome after stroke.

Authors:  Poornima Venkat; Jieli Chen; Michael Chopp
Journal:  J Cereb Blood Flow Metab       Date:  2018-06-11       Impact factor: 6.200

5.  Gene Variant and Level of IL-1β in Ischemic Stroke Patients With and Without Type 2 Diabetes Mellitus.

Authors:  Khouloud Chehaibi; Mohamed Yahia Hrira; Imen Trabelsi; Juan Carlos Escolà-Gil; Mohamed Naceur Slimane
Journal:  J Mol Neurosci       Date:  2015-07-09       Impact factor: 3.444

Review 6.  Inflammatory mechanisms in ischemic stroke: role of inflammatory cells.

Authors:  Rong Jin; Guojun Yang; Guohong Li
Journal:  J Leukoc Biol       Date:  2010-02-03       Impact factor: 4.962

7.  C-reactive protein and aetiological subtypes of cerebral infarction.

Authors:  Alessandro Terruzzi; Laura Valente; Roberto Mariani; Luca Moschini; Massimo Camerlingo
Journal:  Neurol Sci       Date:  2008-09-20       Impact factor: 3.307

8.  The spleen contributes to stroke-induced neurodegeneration.

Authors:  Craig T Ajmo; Dionne O L Vernon; Lisa Collier; Aaron A Hall; Svitlana Garbuzova-Davis; Alison Willing; Keith R Pennypacker
Journal:  J Neurosci Res       Date:  2008-08-01       Impact factor: 4.164

9.  C-reactive protein in the very early phase of acute ischemic stroke: association with poor outcome and death.

Authors:  H M den Hertog; J A van Rossum; H B van der Worp; H M A van Gemert; R de Jonge; P J Koudstaal; D W J Dippel
Journal:  J Neurol       Date:  2009-12       Impact factor: 4.849

10.  Admission C-reactive protein after acute ischemic stroke is associated with stroke severity and mortality: the 'Bergen stroke study'.

Authors:  Titto T Idicula; Jan Brogger; Halvor Naess; Ulrike Waje-Andreassen; Lars Thomassen
Journal:  BMC Neurol       Date:  2009-04-28       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.